Occurrence, treatment and pathogens involved in mastitis on a commercial German dairy farm: A retrospective study from 2012 to 2021
Keywords:
Bovine; udder inflammation; cow; milk; livestock; AMSAbstract
Objective: Mastitis is the most common and costly dairy cow disease worldwide. We performed an intensive analysis of mastitis prevalence, pathogens, and treatments using retrospective data from a commercial dairy farm in Germany to estimate the severity of mastitis in the commercial production system and to give on-farm insights. Material and Methods: Milking system data and cow-individual data were collected over 9 years (2012-2021). A resilient amount of data from 1537 cows, >1,000 mastitis infections, 1901 pathogens, and 5729 treatments have been analyzed. Results: Mastitis occurrence was highest in summer (45.0%), in first lactation (51.1%), and in the late lactation stage (36.7%). The relative mastitis frequency increased sharply with a high lactation number (>7). The leading pathogens causing mastitis were coagulase-negative staphylococci (28.3%). Approximately 25% of mastitis cases were treated with non-antibiotic medicine and 75% with antibiotics. For the latter, cephalosporins and aminoglycosides were the most administered. The average mastitis treatment duration was 3.48 days. During the study time, the farm changed from a conventional milking system to an automatic milking system in 2015, which has not negatively affected the number of recorded mastitis infections. Conclusion: This case report gives detailed insights about mastitis incidences gained under practical conditions. Novel information about mastitis drug usage and duration is presented. Potential mastitis risk factors identified from the results of this study were the summer season, first or >7 lactation(s), and the late lactation stage.
J. Adv. Vet. Anim. Res., 11(4): 856–868, December 2024
Downloads
25
22
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Tina Kabelitz, Olivier Basole Kashongwe, Marcus Doherr, Ulrich Nübel, Christian Ammon, Pablo Silva Boloña, Orla Keane, Thomas Amon, Barbara Amon

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors who publish with this journal agree to the following terms:
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).